ALC - Alcon AG - Stock Price & Dividends
Exchange: USA Stocks • Country: Switzerland • Currency: USD • Type: Common Stock • ISIN: CH0432492467
Eye Care, Surgical, Intraocular Lenses, Contact Lenses, Ocular Health Products
Alcon AG is a global leader in the eye care industry, dedicated to improving vision and enhancing the quality of life for people around the world. The company's comprehensive portfolio of products and services caters to the needs of eye care professionals and their patients, offering a wide range of innovative solutions for various eye care applications.
The Surgical segment of Alcon AG is a pioneer in the development of cutting-edge technologies and products for surgical procedures. This includes advanced equipment, instrumentation, and diagnostics, such as the Centurion vision system, LenSx laser system, and ARGOS biometer, which enable surgeons to perform complex procedures with precision and accuracy. The company's intraocular lenses (IOLs) and implantables, like the AcrySof IQ products, are designed to correct presbyopia and astigmatism during cataract surgery. Additionally, Alcon's consumables, including viscoelastics, surgical solutions, and incisional instruments, support surgeons in achieving optimal outcomes for their patients.
Alcon AG's vitreoretinal products are designed to treat complex eye conditions, such as retinal detachment and diabetic retinopathy. The company's constellation vision systems, procedure packs, and lasers, as well as its grieshaber and MIVS instruments, provide surgeons with the tools they need to perform delicate procedures. Furthermore, Alcon's refractive surgery products, including WaveLight lasers and Contoura Vision, enable surgeons to perform LASIK treatment with precision and accuracy.
The Vision Care segment of Alcon AG focuses on providing innovative contact lenses and ocular health products to improve the quality of life for people with vision impairments. The company's daily disposable, reusable, and color-enhancing contact lenses offer comfort and convenience for wearers. Alcon's ocular health products, including dry eye, glaucoma, and contact lens care solutions, help to manage and treat various eye conditions. The company's ocular vitamins and redness relievers promote overall eye health and well-being.
With a rich history dating back to 1945, Alcon AG has evolved into a global leader in the eye care industry, driven by its commitment to innovation, quality, and customer satisfaction. Headquartered in Geneva, Switzerland, the company continues to push the boundaries of eye care technology, providing innovative solutions that improve the lives of people around the world.
Drawdown (Underwater) Chart
Overall Trend and Yearly Seasonality
ALC Stock Overview
Market Cap in USD | 48,180m |
Sector | Healthcare |
Industry | Medical Instruments & Supplies |
GiC SubIndustry | Health Care Equipment |
TER | 0.00% |
IPO / Inception | 2019-04-09 |
ALC Stock Ratings
Growth 5y | 60.1 |
Fundamental | 54.2 |
Dividend | 50.1 |
Rel. Performance vs Sector | 0.20 |
Analysts | 4.25/5 |
Fair Price Momentum | 92.95 USD |
Fair Price DCF | 57.19 USD |
ALC Dividends
Dividend Yield 12m | 0.28% |
Yield on Cost 5y | 0.46% |
Dividends CAGR 5y | 4.02% |
Payout Consistency | 99.4% |
ALC Growth Ratios
Growth 12m | 15.44% |
Growth Correlation 12m | 86% |
Growth Correlation 3m | 79% |
CAGR 5y | 10.31% |
CAGR/Mean DD 5y | 0.99 |
Sharpe Ratio 12m | 0.43 |
Alpha vs SP500 12m | -9.81 |
Beta vs SP500 5y weekly | 1.13 |
ValueRay RSI | 38.63 |
Volatility GJR Garch 1y | 20.96% |
Price / SMA 50 | 2.37% |
Price / SMA 200 | 12.88% |
Current Volume | 1074.3k |
Average Volume 20d | 788.5k |
External Links for ALC Stock
Wall Street Journal • Benzinga • Yahoo Finance
Tweets
X • Stocktwits
Fund Manager Positions
Dataroma • Stockcircle
As of September 08, 2024, the stock is trading at USD 94.66 with a total of 1,074,325 shares traded.
Over the past week, the price has changed by -3.09%, over one month by +3.85%, over three months by +2.87% and over the past year by +14.11%.
According to ValueRays Forecast Model, ALC Alcon AG will be worth about 103.1 in September 2025. The stock is currently trading at 94.66. This means that the stock has a potential upside of +8.88%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 101.5 | 7.26 |
Analysts Target Price | 93.3 | -1.44 |
ValueRay Target Price | 103.1 | 8.88 |